The groundbreaking approach of this peptide represents a major advance in the care of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide146188.pages10.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-77465010